Silverarc Capital Management, LLC Mirati Therapeutics, Inc. Call Options Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$36.13 - $49.49 $5.42 Million - $7.42 Million
150,000 New
150,000 $5.42 Million
Q3 2022

Oct 28, 2022
SELL
$59.5 - $86.7 $3.47 Million - $5.06 Million
-58,400 Reduced 57.88%
42,500 $2.97 Million
Q2 2022

Jul 25, 2022
BUY
$39.16 - $88.71 $3.95 Million - $8.95 Million
100,900 New
100,900 $6.77 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email